VEDBAEK, Denmark, Jan. 24, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of the 3rd generation of ...
Retrospective analysis of surgery in metastatic GIST patients sensitive to imatinib: A Spanish Group for Research on Sarcoma (GEIS) study. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback